Replies to post #141514 on Biotech Values

[mcbio]

Now I am more bullish on the INCY compound than the PFE compound. But, want to see the long term tox in animals for INCY, and they longer term exposures and results in man for immunosuppression risk.

What about the JAK-1 specific Galapagos drug now partnered with ABT? It seems like that drug has the potential to be one of the best in the class, but it obviously has the furthest to go in the clinic and, of course, the most still to prove.